Rethinking Breast Cancer Screening: Ultra FAST Breast Magnetic Resonance Imaging
Menée sur 443 femmes présentant un risque faible ou modéré de cancer du sein, cette étude évalue, par rapport à une IRM standard, la performance d'un protocole d'IRM, comportant une phase d'acquisition des images de courte durée et la reconstruction de ces images par projection du maximum d'intensité, pour diagnostiquer un cancer du sein
Breast cancer screening is once again controversial. It is hard to miss headlines stating that mammography is an imperfect screening test, missing biologically aggressive cancers and picking up indolent cancers that do not need treatment.We,who have devoted our lives to fighting breast cancer, have long been aware of the limitations of mammography, especially in women with extremely dense breast tissue. Mammography, for all its limits, is still the only test proven to decrease mortality in multiple randomized controlled trials and
through experience with population-based screening. Detecting small cancers on imaging before they are palpable improves survival, as well as treatment options. Yet, questions persist. Does the test pick up too much and still not enough; is it wrong too often ?
Journal of Clinical Oncology , éditorial, 2014